Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Clovis Oncology Inc. Stock

Price
 
€5.95
1.21
24.380%
Target price
€9.50
13.11.19 / Tradegate WKN: A1JPJY / Symbol: CLVS / Name: Clovis Oncology / Stock / Biotechnologie & medizinische Forschung
Latest predictions
€7.00
10.11.19
buy
-
09.11.19
€0.000
09.11.19
€12.00
19.08.19
buy
€66.12
18.10.18
buy
Your prediction

Clovis Oncology Inc. Stock

Clovis Oncology Inc. dominated the market today, gaining €1.21 (24.380%).
With 3 Buy predictions and 2 Sell predictions the community is currently undecided on Clovis Oncology Inc..
As a result the target price of €9.00 shows a very positive potential of 51.362% compared to the current price of €5.95 for Clovis Oncology Inc..
Register To Post

Other discussions about Clovis Oncology Inc. Stock

New thread

News

Clovis Oncology Announces Reimbursement for Rubraca® (rucaparib) Tablets for Women with Relapsed Ovarian Cancer in Italy


Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the Italian Medicines Agency (AIFA) has approved rucaparib for reimbursement in Italy. Rucaparib will soon be available as an option for

Clovis Oncology Announces Third Quarter 2019 Operating Results


Clovis Oncology, Inc. (NASDAQ:CLVS) reported financial results for the quarter ended September 30, 2019, and provided an update on Clovis’ clinical development programs and regulatory and